BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7682560)

  • 1. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.
    Cohen P; Peehl DM; Stamey TA; Wilson KF; Clemmons DR; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1031-5. PubMed ID: 7682560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.
    Kanety H; Madjar Y; Dagan Y; Levi J; Papa MZ; Pariente C; Goldwasser B; Karasik A
    J Clin Endocrinol Metab; 1993 Jul; 77(1):229-33. PubMed ID: 7686915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
    Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor.
    Flyvbjerg A; Mogensen O; Mogensen B; Nielsen OS
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2308-13. PubMed ID: 9215312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids.
    Honda Y; Landale EC; Strong DD; Baylink DJ; Mohan S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1389-96. PubMed ID: 8636339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.
    Pucilowska JB; Davenport ML; Kabir I; Clemmons DR; Thissen JP; Butler T; Underwood LE
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1516-21. PubMed ID: 7505287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions.
    Nonoshita LD; Wathen NC; Dsupin BA; Chard T; Giudice LC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1249-55. PubMed ID: 7525630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.
    Matsumoto T; Gargosky SE; Iwasaki K; Rosenfeld RG
    J Clin Endocrinol Metab; 1996 Jan; 81(1):150-5. PubMed ID: 8550744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity.
    Fielder PJ; Thordarson G; Talamantes F; Rosenfeld RG
    Endocrinology; 1990 Nov; 127(5):2270-80. PubMed ID: 1699743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
    Lee DY; Kim SJ; Lee YC
    J Korean Med Sci; 1999 Aug; 14(4):401-4. PubMed ID: 10485619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.